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y of King
d hostinAbstract Albendazole (ABZ), a broad-spectrum anthelmintic agent, is poorly absorbed after oral
administration due to its low aqueous solubility. The aim of this study was to improve albendazole
dissolution rate by formulating avicel pellets loaded with 10% w/w drug using extrusion/spheron-
ization technique. In addition the wet masses were characterized by mix torque rheometry (MTR)
prior to pelletization process. Different additives (i.e., lactose, Tween 80 and low molecular weight
chitosan) were formulated with avicel to enhance the dissolution rate of ABZ from the produced
pellets. Moreover, mix torque rheometer was used to quantitatively determine the suitable moisture
content in the pastes before the extrusion process. The produced pellets were characterized for their
ABZ content, particle size, particle shape, dissolution proﬁle and thermal behaviors. The maximum
consistencies (the peak torques) of the wet granules were obtained using 0.667–1.333 ml/g of water
or water containing surfactant. Also, the produced pellets have size range from 1036 to 1246 lm.
The calculated drug RDR30 for 10%, 30% and 50% lactose concentrations were 1.08, 1.08 and
2.03, respectively, while that calculated for 10%, 30% and 50% w/w chitosan concentrations were
1.71, 3.62 and 3.62, respectively. The results revealed also that increasing the weight ratio of lactose
and chitosan was accompanied by a signiﬁcant reduction of the peak torque magnitude and this was
accompanied by an enhanced ABZ dissolution rate.
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g by Elsevier1. Introduction
Albendazole (ABZ), methyl [5-(propylthio)-l-H-benzimidazol-
2yl] carbamate, is undoubtedly the most effective of the
broad-spectrum anthelmintic agents (Cook, 1990). The alben-
dazole therapy is very important in systemic cestode infections
specially in inoperable or disseminated cases of hydatidosis
(Wen et al., 1993) and neurocysticercosis (Del-Brutto et al.,
1993). The biggest problem of using ABZ, as a member ofier B.V. All rights reserved.
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result of its low aqueous solubility (Torrado et al., 1996).
This property is a major disadvantage for the use of ABZ in
the treatment of systemic helminthiasis (Yasawy et al., 1993).
Furthermore, the lack of water solubility reduces ﬂexibility
for ABZ formulation and administration. Therefore, the over-
come of poor aqueous solubility of ABZ is important and
needed.
ABZ solubility has been enhanced using different tech-
niques. For example, solid dispersion systems of ABZ were
mixed with varying concentrations of polyvinylpyrrolidone
(PVP K 12) in an attempt to improve the solubility and disso-
lution rate of the drug (Torrado et al., 1996). The ABZ disso-
lution rate, expressed as the dissolution efﬁciency, and also the
solubility coefﬁcient were increased when the drug was mixed
with PVP. Also, in our previous report showed (Alanazi
et al., 2007) improving the dissolution rate of ABZ by produc-
ing microparticles with certain hydrophilic polymers such as
hydroxypropyl methylcellulose (HPMC), polyvinyl alcohol
(PVA), and polyvinyl pyrrolidone (PVP) using spray drying
technique. Recently, formulation of drug in multiparticulate
dosage forms (pellets) is considered as one of the solubility
improving mechanisms due to the great surface area of pellets
which enhanced drug solubility. Jachowicz et al. (2000) im-
proved the dissolution rate of ketoprofen by incorporating
the solid dispersion of the drug with macrogol and kollagen
in the form of pellets.
The interest in pellets as dosage forms has been increasing
continuously. Pellets as a drug delivery system offer therapeu-
tic advantages such as less irritation of the gastro-intestinal
tract and a lowered risk of side effects due to dose dumping
(Bechgaard and Nielsen, 1978). In addition, technological
advantages are present, for example, better ﬂow properties less
friable dosage form, narrow particle size distribution, ease of
coating and uniform packing. The reproducibility of the drug
blood levels (Eskilson, 1985) is an additional advantage to the
use of a pellet formulation. The in vitro release rate of hydro-
chlorothiazide from Avicel PH101 pellets was enhanced by the
incorporation of polyethylene glycol 400 and PEG-40 hydro-
genated castor oil (Vervaet et al., 1994).
Extrusion and spheronization are currently one of the tech-
niques used to produce pharmaceutical pellets. The prepara-
tion of spherical granules or pellets by extrusion and
spheronization is now a more established method because of
its advantages over the other methods (Chambliss, 1989;
Robinso and Hollenbeck, 1991). With each production tech-
nique, pellets with speciﬁc characteristics are obtained. One
of the important steps in preparing pellets with this method
is optimal wet mass production. The amount of water added
at the maximum torque should be comparable with that found
for the optimum production of pellets during spheronization
(Paul et al., 2009). Also, moisture content of the wet mass is
the most critical variable for pellet growth in the extrusion
spheronization process because it provides the required plastic-
ity and cohesiveness to the powder to extrude the wet mass and
spheronize it to give a spherical shape. An optimum quantity
of moisture content should be there to obtain pellet of accept-
able quality (Kleinebudde, 1993). It has been shown that the
rheological properties of wet masses can be successfully mon-
itored by a mixer torque rheometer (Parker et al., 1990a,b;
Rowe and Parker, 1994; Chatlapalli and Rohera, 1998). The
use of the mixer torque rheometer (MTR) as an upfront ana-lytical tool can greatly reduce the number of development
batches. This equipment has been shown to be an excellent
tool for the evaluation of wet granulated systems and as a
scale-up tool for high shear granulations (Hancock et al.,
1991). Several authors have compared the rheological proper-
ties of different MCC grades (Rowe and Sadeghnejad, 1987;
Parker and Rowe, 1991; Hancock et al., 1992), but the rheo-
logical properties of some additives on microcrystalline cellu-
lose have not been studied previously.
According to Parker et al. (1990a,b), the degree of liquid
spreading and wetting as well as the substrate binder interac-
tion will determine the relative positions of the peak values
of mean line torque. Any change in the mean torque with
the increase in the binder level at different concentrations
either a sharp or an extended peak might inﬂuence the attri-
butes of the produced pellets.
The objective of this study was to formulate ABZ-loaded
pellets using extrusion/spheronization technique in order to
improve drug dissolution rate. The prepared pellets were char-
acterized for their particle sizes and morphology, drug content
and the in vitro drug release as well. In addition, the effect of
additives on the pellets properties was studied. The binder ra-
tio required for the preparation of wet mass prior to the pellet-
ization process was measured by the mix torque rheometer.
Moreover, the relation between wet mass consistency with bin-
der ratio and their impact on the dissolution behavior of ABZ
from pellets was studied.2. Materials and methods
2.1. Materials
Albendazole (ABZ) was kindly donated from Saudi Pharma-
ceutical Industries (Riyadh, SA). Microcrystalline cellulose
(Avicel PH101) was purchased from Serva Feinbiochemica
(Heidelberg, Germany). Lactose monohydrate was purchased
from Winlab (Leicestershire, UK). Polyoxyethylene (20) sorbi-
tan monooleate (Tween 80) was purchased fromMerck Com-
pany (Muenchen, Germany). Chitosan, low MWt grade
(Brookﬁeld viscosity 20000 cp) was purchased from Sigma–Al-
drich Chemie, GmbH (Steinheim, Germany). All other materi-
als and solvents used are of reagent or analytical grade and they
were used without further puriﬁcation.2.2. Methods
2.2.1. Wet massing studies using a mixer torque rheometer
Drug substance and excipients were mixed in turbula mixer
(type S27, Erweka, Apparatebau, Germany). A 15 g sample
of this dry blend was utilized in these studies. Five milliliters
of granulating ﬂuid (deionized. water with or without Tween
80) were added in multiple additions over 7 wet massing inter-
vals. Each wet massing interval consisted of a 1-min mixing
period and a 20-s data logging (collection) period with the
mixer torque rheometer (MTR) operating at 50 rpm (MTR-
3, Caleva, Dorset, England). Mean line torque was monitored
during the granulation process. The data acquisition and anal-
yses were carried out by a personal computer using data acqui-
sition system and software package supplied by the equipment
manufacturer.
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Pellets were prepared from those wet masses showing highest
mean torque. The tested additives (avicel, lactose and chitosan)
and ABZ were mixed in turbula mixer at 9.5:0.5 weight ratio
(type S27, Erweka, Apparatebau, Germany). The powder mix-
ture was wetted with the granulation ﬂuid (water containing
different concentrations of the surfactant) depending on the
composition of the formulation (Table 1). Next, the resulting
wet mass was extruded at a speed of 90 rpm (Mini Screw Ex-
truder, Model MSE1014, Caleva, Dorset, England), through
1 mm diameter die. Spheronization was performed in a spher-
onizer (Model 120, Caleva, Dorset, England) with a rotating
plate of regular cross-hatch geometry, at a speed of 700 rpm,
for 5 min. Pellets were then dried on a tray in a hot oven at
50–60 C for 6 h.
2.2.3. Determination of ABZ content in the prepared pellets
Albendazole content of the prepared pellets was determined
spectrophotometrically (UV-9100 Spectrophotometer, Beijing
Rayleigh Analytical Instruments Corp., China) at 290 nm in
triplicate (Alanazi et al., 2007). Pellets were crushed in a porce-
lain mortar and about 25 mg of ABZ-loaded pellets were dis-
persed in 20 ml phosphate buffer (pH = 6.8) under
sonication. The solution was ﬁltered and ABZ amount was
measured.
2.2.4. Particle size analysis of the prepared pellets
The size distribution of the prepared pellets was investigated
using laser light diffraction particle sizer (Mastersizer Master-
sizer Scirocco 2000, Malvern Instruments, Grovewood Road,
UK). For a typical experiment, about 300 mg of pellets were
loaded in the sample micro feeder. All samples were analyzed
5 times and average results were taken. The sizes below which
10% (d(0.1)), 50% (d(0.5)) and 90% (d(0.9)) of the pellets were
used to characterize the pellets size distribution. The mean
diameter was taken as the average of d(0.1), d(0.5) and d(0.9)
values.
2.2.5. Morphological analysis of the prepared pellets
The morphological characteristics of prepared pellets were ob-
served by scanning electron microscopy (SEM). The samples
were sputter-coated with thin gold palladium layer under an
argon atmosphere using a gold sputter module in a high-
vacuum evaporator. The coated samples were then scannedTable 1 Composition of pellets formulae containing 10% w/w albe
Formula Ingredient (% w/w)
Avicel PH101 Lactose anhydrous
ABZ 1 100 –
ABZ 2 90 10
ABZ 3 70 30
ABZ 4 50 50
ABZ 5 50 50
ABZ 6 50 50
ABZ 7 50 50
ABZ 8 90 –
ABZ 9 70 –
ABZ 10 50 –
a Dissolved in water.and photomicrographs were taken with an SEM (Jeol JSM-
1600, Tokyo, Japan).
2.2.6. Thermal analysis
Physical mixtures of ABZ with the tested pellet excipients (lac-
tose, chitosan and Tween) as well as the individual components
were investigated for their interactions. The samples (3–5 mg)
were hermetically sealed in aluminum pans and heated at a con-
stant rate of 10 C/min, over a temperature range of 25–250 C.
Thermograms of the samples were obtained using differential
scanning calorimetry (DSC-60, Shimadzu, Japan). Thermal
analysis data were recorded using a TA 50I PC system with Shi-
madzu software programs. Indium standard was used to cali-
brate the DSC temperature and enthalpy scale. N2 was used
as purging gas at the rate of 30 ml/min.
2.2.7. In vitro release studies of the prepared pellets
In vitro drug release was performed for the ABZ-loaded pellets
using a USP dissolution test apparatus. The dissolution of
ABZ from the prepared pellets was monitored using an auto-
mated dissolution tester (LOGAN Instrument Corp., Somer-
set, NJ, USA) coupled to an automated sample collector
(SP-100 peristaltic pump, Somerset, NJ, USA). The USP appa-
ratus I (basket method) was used at 100 rpm. The media used
were 500 ml of 0.1 N HCl at a pH 1.2 maintained at
37 ± 0.5 C. The amount of ABZ released from pellets was
determined by UV spectrophotometer (UV-1800, Shimadzu,
Tyoto, Japan) at 290 nm. The dissolution experiments were
carried out in triplicate.
2.2.8. Kinetic assessment of the in vitro release of MCP from the
prepared pellets
In order to determine the release model which best describes
the pattern of drug release, the in vitro release data were ﬁtted
to zero order, and diffusion controlled release mechanisms
according to the simpliﬁed Higuchi (1963) model.
3. Results and discussion
3.1. Wet massing studies
Experiments were performed in order to establish the massing
binder ratio needed to reach an equilibrium torque response.
Figs. 1 and 2 show the rheological proﬁles for Avicel PH101ndazole.
Chitosan (low MWt) Tween 80a Dist. water
– – Q.S.
– – Q.S.
– – Q.S.
– – Q.S.
– 5 Q.S.
– 10 Q.S.
– 20 Q.S.
10 – Q.S.
30 – Q.S.
50 – Q.S.
218 M.A. Ibrahim, F.K. Al-Anaziwhen mixed at different ratios with lactose and chitosan,
respectively. It is evident that there is an increase in torque
with increasing liquid content, rising to a maximum, and then
decreasing as larger volumes of binder are used.
The MTR behavior of avicel alone showed that the peak
torque was 0.943 N m and was achieved by using a binder ratio
of 1.333 mL/g. Considering avicel–lactose system, increasing
the weight ratio of lactose was accompanied by both a reduc-Figure 1 Effect of different avicel:lactose concentrations on mean
formula composition with binder ratio and peak torque.
Figure 2 Effect of different avicel:chitosan concentrations on mean
formula composition with binder ratio and peak torque.tion in the wet mass peak torque and at the same time a reduc-
tion in the binder ratio required for wet massing. For example,
the peak torque of avicel:lactose (9:1 w/w) mixture was
0.658 N m with a binder ratio of 1 mL/g, while the peak torque
of avicel:lactose (1:1 w/w) mixture was 0.156 N m with a bin-
der ratio of 0.667 mL/g, Fig. 1.
The MTR characteristics of avicel–chitosan systems
showed different proﬁles, in which the curves become moretorque the wet mass. Also, the table shows the relation between
torque the wet mass. Also, the table shows the relation between
Figure 3 Effect of water containing different concentrations of Tween 80 on mean torque for avicel–lactose wet mass. Also, the table
shows the relation between formula composition with binder ratio and peak torque.
Enhancement of the dissolution of albendazole from pellets 219broad (higher binder ratios were consumed in the transforma-
tion from pendular and capillary phases). Also, increasing
chitosan concentration resulted in decreasing the peak torque
of the wet mass, Fig. 2. This might be due to the lower afﬁnity
of chitosan to absorb water when compared to avicel.
Furthermore, addition of Tween 80 to avicel:lactose (1:1 w/
w) mixture system did not affect both the peak torque and the
binder ratio of the wet masses, Fig. 3, with an exception of 5%
w/v Tween 80 concentration. For example, the peak torque of
avicel:lactose (1:1 w/w) mixture containing 10% Tween 80 was
0.158 N m while the peak torque of such mixture containing
20% Tween 80 was 0.159 N m.
The degree of liquid spreading and wetting as well as the
substrate binder interaction determine the relative positions
of the peak values of mean line torque. An increase in the
mean torque with the increase in the binder level at different
concentrations either a sharp or an extended peak followed
by a drop in the torque as over-wetting of the powder mass
occurred (Parker et al., 1990a,b). In addition, the pendular
and funicular states are characterized by progressively
increasing the network of liquid bridges. Both these stagesTable 2 Volume weighted mean particle size and the d(0.1), d(0
albendazole (10% w/w as determined by laser diffractometry.
Pellets formulae Mean (lm) d(0.1)
ABZ 1 1113.59 792.7
ABZ 2 1116.21 796.5
ABZ 3 1189.73 865.7
ABZ 4 1246.80 916.1
ABZ 5 1016.34 737.0
ABZ 6 1093.49 694.3
ABZ 7 1165.78 847.8
ABZ 8 1115.19 794.3
ABZ 9 1118.79 799.6
ABZ 10 1036.00 708.5cause an increase in cohesiveness of the powder mass, and
hence an increased torque on the mixer (Parker et al.,
1990a,b). The capillary state which is reached when all the
air spaces in the granular material are ﬁlled with liquid occurs
at the maximum on the curve. With further addition of liquid
the torque decreases as slurry of particles dispersed in liquid
is formed.
3.2. Drug content
The drug content data of 10% ABZ-loaded pellets are listed in
Table 3. The data show that ABZ was efﬁciently loaded into
the pellets and the actual ABZ content ranged between
9.66% and 10.45%. It is evident that there is an inverse pro-
portionality between the concentration of Tween added and
the pellet drug content. The addition of Tween 80 to the
formula contains avicel 1:1 lactose (Formulae ABZ 5–7), dur-
ing pellet preparation lowered the drug content. This decrease
in drug content is directly proportional to the Tween concen-
tration and might be due to that these Tween 80 did not evap-
orate during pellet drying. It is evident also that pellet drug.5) and d(0.9) values of different pellet formulae loaded with
(lm) d(0.5) (lm) d(0.9) (lm)
3 1088.67 1468.12
4 1091.29 1469.65
3 1171.33 1550.12
2 1232.14 1587.39
3 988.98 1342.75
8 1053.16 1556.31
6 1145.82 1519.24
9 1090.45 1469.36
6 1094.42 1470.81
0 1008.52 1401.89
220 M.A. Ibrahim, F.K. Al-Anazicontent in the presence of chitosan or lactose shows no statis-
tically difference than pellets prepared from avicel alone
(p< 0.05).
3.3. Size of the pellets
The volume weighted mean particle size, the d(0.1), d(0.5) and
d(0.9) values of different pellet formulae loaded with ABZ
(10% w/w as determined by laser diffractometry) are listedFigure 4 Effect of different Tween 80 concentrations on particle
size (volume weighted mean) of pellets prepared from avicel:lac-
tose (formulae ABZ 5–ABZ 7). The included table relates the
mean line torque of wet mass and pellet particle size.
Figure 5 Scanning electron micrographsin Table 2. Generally, the produced pellets have size range
from 1036 to 1246 lm. Concerning avicel–lactose pellets, the
increase in lactose concentration caused a pronounced in-
crease in the pellets sizes. The size of pellet formula ABZ 2
(based on 10% lactose) is 1116.21 lm, for ABZ 3 (based on
30% lactose) was 1189.73 lm, while for formula ABZ 4 (based
on 50% lactose) is 1246.80 lm as shown in Table 2. Upon the
addition of Tween 80 in the manufacture of avicel–lactose pel-
lets (formulae ABZ 5–ABZ 7), the pellet size became smaller
noticeably (1016.34, 1093.49 and 1165.78 lm were recorded
for formulae ABZ 5, ABZ 6 and ABZ 7, respectively). This re-
sult correlates well with the results of MTR, in which the mean
torque value increases by increasing Tween 80 concentration
and the pellet size becomes larger with the increase in mean
line torque value, Fig. 4. This increase in the pellet size by
increasing the wet mass torque (cohesiveness) might be due
to the difﬁculty in the extrusion and spheronization of the
wet mass of the higher torque value, which leads to a larger
size, i.e., cutting of the particle becomes hard due to the high
force of cohesiveness between particles. Avicel–chitosan pellets
prepared from lower chitosan concentration showed particle
sizes that are slightly larger than those prepared from higher
chitosan levels, Table 2. This could be explained on the basis
of the slightly lower peak torque of pellets prepared from
higher chitosan levels, which result also in increasing ABZ dis-
solution rate.
3.4. Morphological analysis of the prepared pellets
Scanning electron micrographs of ABZ pellets of different
compositions are displayed in Fig. 5. The resulting pellets wereof different ABZ pellet formulations.
Figure 6 DSC curves of ABZ pellet formulations compared to the individual components.
Figure 7 Effect of different avicel:lactose concentrations on the
in vitro release proﬁles of ABZ from pellet formulations.
Enhancement of the dissolution of albendazole from pellets 221spherical and intact in shape. The pellets showed slightly rough
surfaces. It should be noted that pellets formulated from avicel
only exhibited incomplete spherical shapes. In addition, pellets
composed of avicel–chitosan showed highly rough surfaces,
which could be explained on the base of the surface nature
of chitosan powder and solubility in the massing liquid
(water). However, lactose and Tween 80 (Formula ABZ 4
and 7, respectively) improved surface properties of the manu-
factured pellets. This might be due to the hydrophilic nature of
lactose, in which lower mean torques as well as lower binder
ratios were observed upon increasing the lactose weight ratio.
Law and Deasy (1997) reported that the use of hydrophilic
polymers with avicel favored more spherical and smooth
pellets.
3.5. Thermal analysis
The DSC thermograms of pure ABZ (Fig. 6) show an endo-
thermic peak at 218 C with a shoulder at 198 C due to the
drug melting (Alanazi et al., 2007). In addition, two peaks were
recorded upon DSC scanning of lactose at 144 and 231 C.
However, no melting peak was detected for avicel. The DSC
thermographs of ABZ when formulated as pellets with differ-
ent excipients show that the characteristic drug peak was com-
pletely disappeared, which could be attributed to the solubility
of ABZ in the molten polymers (Mahrous et al., 2010).
3.6. In vitro release of ABZ from the prepared pellets
The in vitro dissolution proﬁles of ABZ of the avicel pellet for-
mulations containing different concentrations of lactose are
illustrated in Fig. 7. It is clear from the ﬁgure that the release
rate of ABZ from pellets prepared from avicel only was very
slow (only 27.66%± 2.48 was dissoluted after 90 min). The
addition of lactose improved the dissolution rate of the drug,
especially at higher lactose concentrations. The calculated drug
RDR30 for 10%, 30% and 50% lactose concentrations were
1.08, 1.08 and 2.03, respectively, Table 3. The enhanced disso-
lution rate of ABZ upon addition of lactose might be due to
the hydrophilic nature of lactose (Jamzad and Fassihi, 2006).
One could see that increasing the weight ratio of lactose was
accompanied by a signiﬁcant reduction of the peak torque
magnitude and this was accompanied by an enhanced ABZdissolution rate. When different Tween 80 concentrations were
added to avicel–lactose pellets (50:50), the in vitro ABZ disso-
lution was not signiﬁcantly affected, Fig. 8. The recorded D90
for 5%, 10% and 20% w/w of Tween were 57.01 ± 2.25,
57.87 ± 2.25 and 62.54 ± 5.21, respectively, while 56.21%
± 1.17 dissoluted in the absence of Tween 80, Table 3. This
might be due to a fact that increasing the weight ratio of
Tween 80 did not affect the value of peak toque of avicel–lac-
tose (50:50) paste during pellet formulation, which correlates
with the ABZ dissolution data.
The in vitro ABZ dissolution proﬁles from pellet formula-
tions prepared from avicel and chitosan at different weight
ratios was investigated and the results are displayed in Fig. 9.
ABZ exhibited the highest dissolution rate from avicel–chito-
san pellet formulations containing 30% and 50%w/w chitosan.
The recorded D90 values for 10%, 30% and 50% w/w chitosan
concentrations were 47.24 ± 0.94, 100.00 ± 1.81 and
100.00 ± 6.03, Table 3. It is worthy to note that at the ﬁrst
30 min, chitosan pellets formulated with 30% and 50% w/w
Table 3 Albendazole content, percentage albendazole dissolved after 30 min (D30) and 90 min (D90) as well as relative dissolution rate
at 90 min (RDR90) from its loaded Avicel PH101 pellets.
Pellets formulae ABZ content (%w/w) D30 D90 RDR90
ABZ 1 10.20 ± 0.41 13.27 ± 1.17 27.66 ± 2.48 –
ABZ 2 9.89 ± 0.37 14.16 ± 0.12 29.86 ± 0.01 1.08
ABZ 3 9.78 ± 0.85 19.08 ± 1.78 38.40 ± 3.34 1.39
ABZ 4 10.45 ± 0.56 31.35 ± 0.02 56.21 ± 1.17 2.03
ABZ 5 9.73 ± 0.35 32.82 ± 1.50 57.01 ± 2.25 2.06
ABZ 6 9.66 ± 0.26 30.56 ± 1.72 57.87 ± 2.55 2.09
ABZ 7 7.81 ± 0.16 32.22 ± 1.23 62.54 ± 5.21 2.26
ABZ 8 9.88 ± 0.59 21.42 ± 0.62 47.24 ± 0.94 1.71
ABZ 9 10.12 ± 0.45 56.67 ± 2.80 100.00 ± 1.81 3.62
ABZ 10 10.25 ± 0.67 57.89 ± 3.47 100.00 ± 6.03 3.62
Figure 8 Effect of different concentrations of Tween 80 (%w/w)
on the in vitro release proﬁles of ABZ from ABZ 4 pellet
formulation.
Figure 9 Effect of different avicel:chitosan concentrations on the
in vitro release proﬁles of ABZ from pellet formulations.
Table 4 Kinetic modeling and ﬁrst order release rate constant
values for the prepared albendazole pellets.
Formula Correlation coeﬃcient K1 (min
1) 104
Zero order First order Higuchi model
ABZ 1 0.9806 0.9904 0.7951 34.8
ABZ 2 0.9785 0.9894 0.8013 36.7
ABZ 3 0.9754 0.9907 0.8175 49.8
ABZ 4 0.8588 0.9902 0.8680 82.1
ABZ 5 0.9552 0.9891 0.8773 83.2
ABZ 6 0.9748 0.9973 0.8286 96.8
ABZ 7 0.9858 0.9846 0.8063 129.9
ABZ 8 0.9790 0.9955 0.7840 69.5
ABZ 9 0.8952 0.9759 0.8060 463.6
ABZ 10 0.9011 0.9761 0.8416 439.8
222 M.A. Ibrahim, F.K. Al-Anazichitosan began to rupture and completely disintegrated after
90 min. This phenomenon might be the cause of the rapid dis-
solution rate from these formulae. Some factors may contribute
to the enhanced dissolution rate of ABZ from chitosan pellets
especially those prepared from% 30 and 50% w/w chitosan.
First, the lower torque values recorded for avicel–chitosan pel-
lets (0.278 and 0.156 N m for avicel 70:30 chitosan and avicel
50:50 chitosan, respectively, Fig. 6). Second, the dispersion of
chitosan in the acidic dissolution buffer (Majeti and Kumar,
2000) facilitates the dissolution rate of ABZ.
3.7. Kinetic assessment of the in vitro dissolution of ABZ from
the prepared pellets
The correlation coefﬁcient (r), and the ﬁrst order release rate
constant of ﬁtting the release data to zero, ﬁrst and Higuchi
diffusion models for spheres are listed in Table 4. The higher
correlation coefﬁcient (r) values for ﬁrst order model were ob-
tained in all formulae that indicate a good ﬁtting with the ﬁrst
order mechanism. It should be mentioned that the tested pellet
formulae did not show any swelling during the dissolution
period. Only chitosan pellets containing higher chitosan levels
were ruptured and disintegrated during dissolution as
mentioned before. The values of ﬁrst order release rate con-
stant (K1) of ABZ dissolution from tablet formulae showed
that chitosan pellets exhibited the most pronounced enhancing
action on ABZ dissolution. The recorded values of K1 were
463.6 · 104 and 439.8 · 104 min1 for pellets containing 30%
and 50% w/w chitosan, Table 4.
Enhancement of the dissolution of albendazole from pellets 2234. Conclusion
From the previous results, it could be concluded that the wet
mass behavior could be helpful in predicting pellets’ shapes
and sizes. Also, the mean line torque of the wet masses could
draw a good picture about the dissolution rate of the drugs
from the prepared pellets. In addition, the presence of hydro-
philic additives as lactose and Tween 80 enhanced the drug dis-
solution rate from the manufactured pellets.Acknowledgment
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